View by Specialty

Trending

Anthony A. Romeo
November 15, 2024
4 min read
Save

Capitalism is the path to value-based care

Retina/Vitreous News

SPONSORED CONTENT
Save
SPONSORED CONTENT
December 06, 2023
1 min watch
Save

VIDEO: Specific OCT signs associated with worsening of myopic macular schisis

VIDEO: Specific OCT signs associated with worsening of myopic macular schisis

ROME — In this Healio Video Perspective from the FLORetina-ICOOR meeting, Ramin Tadayoni, MD, PhD, speaks about myopic macular schisis and the OCT signs that can predict the worsening of this condition.

SPONSORED CONTENT
December 05, 2023
3 min read
Save

World Geographic Atrophy Day aims to empower individuals, heighten awareness

World Geographic Atrophy Day aims to empower individuals, heighten awareness

Dec. 5 is World Geographic Atrophy Day, a new initiative that seeks to empower individuals with this advanced form of dry age-related macular degeneration and expand global advocacy, education and support efforts.

Trending

Anthony A. Romeo
November 15, 2024
4 min read
Save

Capitalism is the path to value-based care

SPONSORED CONTENT
December 05, 2023
1 min read
Save

Phase 2 trial of EYP-1901 in wet AMD meets all endpoints

Phase 2 trial of EYP-1901 in wet AMD meets all endpoints

The phase 2 DAVIO 2 trial of EYP-1901 met all primary and secondary endpoints in patients with wet age-related macular degeneration, EyePoint Pharmaceuticals announced in a press release.

SPONSORED CONTENT
December 03, 2023
1 min read
Save

Neovascular AMD treatment in ‘last push’ of development; IOL positioning system launches

Neovascular AMD treatment in ‘last push’ of development; IOL positioning system launches

Healio’s top video perspectives from Eyecelerator@AAO include a key update on sozinibercept for neovascular age-related macular degeneration and a launch announcement for the ZeptoLink IOL positioning system.

SPONSORED CONTENT
December 01, 2023
1 min read
Save

Harrow acquires NDA for Triesence

Harrow acquires NDA for Triesence

Harrow announced an early completed transfer of the new drug application for Triesence, a synthetic corticosteroid for treatment of several inflammatory ophthalmic conditions, including those not responsive to topical corticosteroids.

SPONSORED CONTENT
December 01, 2023
1 min read
Save

Positive phase 1 safety data reported for small interfering RNA technology in wet AMD

Positive phase 1 safety data reported for small interfering RNA technology in wet AMD

Positive safety and tolerability data were reported for OLX10212, a small interfering RNA technology, in patients with neovascular age-related macular degeneration, according to a press release from OliX Pharmaceuticals.

SPONSORED CONTENT
November 29, 2023
1 min read
Save

Food, housing insecurity among self-reported barriers to eye care

Food, housing insecurity among self-reported barriers to eye care

Socioeconomic and demographic factors, such as housing insecurity and mental health issues, are associated with a lower likelihood of receiving eye care, according to research published in JAMA Ophthalmology.

SPONSORED CONTENT
November 28, 2023
1 min read
Save

Pegcetacoplan safe, effective over 24 months in patients with geographic atrophy

Pegcetacoplan safe, effective over 24 months in patients with geographic atrophy

NEW ORLEANS — Pegcetacoplan slowed lesion growth and was well-tolerated when given monthly or every other month in patients with geographic atrophy secondary to age-related macular degeneration, according to a presenter at Academy ‘23.

SPONSORED CONTENT
November 28, 2023
3 min watch
Save

VIDEO: Study explores real-world treatment patterns of faricimab for wet AMD

VIDEO: Study explores real-world treatment patterns of faricimab for wet AMD

In this Healio Video Perspective from Retina Subspecialty Day at the AAO meeting, Sophie J. Bakri, MD, discusses outcomes from the FARETINA-AMD study of faricimab as a treatment for age-related macular degeneration.

SPONSORED CONTENT
November 27, 2023
1 min read
Save

Standardized OCT classification, grading system needed for diabetic macular edema

Standardized OCT classification, grading system needed for diabetic macular edema

Despite advances in research on OCT biomarkers of diabetic macular edema, a standardized classification and grading system is still necessary to fill knowledge gaps, according to a recently published review.

View more